- STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and moreVertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorderSTAT · 19d ago↗ source
- How digital health companies are planning to conquer CMS ACCESSA new Medicare experiment to manage seniors’ chronic diseases will pay some digital health companies only about as much in a year as they might earn for a couple of patient visits from commercial i…Endpoints · 19d ago↗ source
- Ebola outbreak exposes a fractured outbreak response systemThe costly threat to employer-based health care, Gen Z doctors, and more health newsSTAT · 19d ago↗ source